Electrical Vestibular Nerve Stimulation (VeNS) as a Treatment for Anxiety in Adolescents
NCT: NCT06956105 · COMPLETED
Brief Summary
Trial title: A Randomized, Double-blind Sham-controlled Clinical Trial to Evaluate The Efficacy of Electrical Vestibular Stimulation (VeNS), Compared to a Sham Control For The Management Of Anxiety in Adolescents - The Modius Calm Adolescent Study The aim of this study: This investigation aims to evaluate the effects of VeNS for the treatment of Generalized Anxiety Disorder, to contribute to the field of knowledge about the neurological mechanisms to determine whether the relatively inexpensive, and non-invasive technique of VeNS can reduce the severity of GAD symptoms in adolescents. Allocation: Randomized to either active device or control device usage. Endpoint classification: Efficacy Study Intervention Model: Parallel Assignment in 1:1 active to control allocation Sample size: The aim is to recruit a total of up to 60 participants. The study will last 12 weeks in total for each subject.
Frequently Asked Questions
What is Electrical Vestibular Nerve Stimulation (VeNS) as a Treatment for Anxiety in Adolescents?
Electrical Vestibular Nerve Stimulation (VeNS) as a Treatment for Anxiety in Adolescents is a clinical trial registered under NCT06956105. Current status: COMPLETED.
What is the status of NCT06956105?
The current status of NCT06956105 (Electrical Vestibular Nerve Stimulation (VeNS) as a Treatment for Anxiety in Adolescents) is: COMPLETED.
When did Electrical Vestibular Nerve Stimulation (VeNS) as a Treatment for Anxiety in Adolescents start?
Electrical Vestibular Nerve Stimulation (VeNS) as a Treatment for Anxiety in Adolescents started on 2025-09-08.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.